|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| (Loss) income before income tax expense | |||||
| Net loss | |||||
| Net (loss) income applicable to common shareholders | |||||
| Basic net loss per share | |||||
| Diluted net loss per share | |||||
| Weighted average common stock shares outstanding - basic | |||||
| Weighted average common stock shares outstanding - diluted | |||||
Loading...